ISIshan D. Shah

Ishan D. Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ishan D. Shah has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Supine ALIF versus Lateral-Decubitus OLIF for Degenerative Lumbar Disease

    by Ishan D. Shah, Puru Sadh, Vikram Sharma, Tasif Mahmoud, Alan H. Daniels, Bryce A. Basques

    Study Design.: Systematic review and meta-analysis. Objective.: To compare outcomes between supine anterior lumbar interbody fusion (ALIF) and lateral decubitus oblique lumbar interbody fusion (OLIF). Background.: ALIF and OLIF differ in surgical corridor and patient positioning, with their relative advantages remaining debated. Methods.: A PRISMA-compliant search of PubMed, Embase, and Google Scholar was performed through April 2026 for studies evaluating anterior versus oblique lumbar interbody fusion. Outcomes included perioperative, complication, patient-reported, and sagittal alignment measures, pooled using fixed- or random-effects models based on heterogeneity (I²>50%). Results.: Thirteen studies (1,432 patients; 795 ALIF, 637 OLIF) met inclusion criteria. OLIF was associated with shorter length of stay (−0.87 days [ 95% CI: −1.47 to −0.26], P =0.005). Leave-one-out analyses demonstrated lower operative time (−39.07 minutes [95% CI: −76.73 to −1.41], P =0.04) and estimated blood loss (−96.32 mL [95% CI: −182.03 to −10.61], P =0.03) favoring OLIF, though substantial heterogeneity persisted. Complications and patient-reported outcomes did not differ. OLIF showed greater reductions in sagittal vertical axis (SVA) immediately postoperatively (−18.32 mm [95% CI: −30.89 to −5.75], P =0.004) and at final follow-up (−9.39 mm [95% CI: −17.83 to −0.96], P =0.03). In a subanalysis of fusions involving the sacrum, OLIF had lower EBL (−182.32 mL [95% CI: −297.38 to −67.27], P =0.002) and shorter LOS (−1.45 days [95% CI: −1.72 to −1.18], P P =0.06). Conclusions.: OLIF appears to offer a modest advantage over ALIF, with shorter hospitalization, comparable complications and patient-reported outcomes, and greater SVA correction. These perioperative benefits could potentially be meaningful in patients with higher comorbidity burden and appeared preserved in fusions involving the sacrum. The SVA correction may reflect advantages of single-position lateral surgery for restoring global alignment. Level of Evidence.: III

  • Smoking Attenuates the Advantages of Cervical Disc Arthroplasty Over Fusion

    by Puru Sadh, Sonia Sheth, Mehek Sharma, Ishan Shah, Tasif Mahmoud, Yatharth Sharma, Leona Tomy, Alan H. Daniels, Bryce A. Basques

    Study Design.: Retrospective cohort study. Objective.: To compare anterior cervical disc replacement (ACDR) and anterior cervical discectomy and fusion (ACDF) in smokers and nonsmokers. Summary of Background Data.: Smoking is a well-established risk factor after fusion-based spine surgery, whereas ACDR does not depend on bony fusion. This prompts interest in ACDR for smokers, but comparative data remain limited. Methods.: Patients aged ≥18 years undergoing ACDR or ACDF for cervical myelopathy or radiculopathy from 2017 to 2023 were stratified by smoking status. Primary outcomes were length of stay (LOS), adjacent segment disease (ASD), reoperation, and subsidence; secondary outcomes were PROMIS Global Mental Health (GMH) and Global Physical Health (GPH) through 2 years. Regression within each stratum adjusted for age, Charlson Comorbidity Index, and operative levels. Procedure-by-smoking interactions were fitted on the full cohort, with Firth penalized regression for sparse outcomes, mixed-effects models for PROMIS, and time-to-event analysis for complications. Results.: 242 patients were included (60 ACDR, 182 ACDF). Among non-smokers, ACDR was associated with lower reoperation (2.4% vs. 13.9%; adjusted OR 3.91, P =0.036) and subsidence (12.2% vs. 25.2%; adjusted OR 2.12, P =0.047), shorter LOS (+0.31 d for ACDF, P =0.006), and higher 2-year GPH (50.5±6.6 vs. 44.1±6.8, P P =0.02); no differences were seen in reoperation, subsidence, ASD, or patient-reported outcomes. In interaction testing, only 2-year GPH reached significance. Conclusions.: The advantages of ACDR among non-smokers were absent in smokers. These findings indicate that smoking may attenuate the procedure-specific advantages of ACDR and that smoking status should be considered a possible determinant of surgical effectiveness. Smoking cessation should be emphasized as an integral component of preoperative counseling and surgical planning, and the choice between ACDR and ACDF in active smokers should be made with the understanding that the expected benefits of ACDR may not be present in this population.